LHC Group Inc. (NASDAQ: LHCG) and BioScrip Inc. (NASDAQ: BIOS) are each other’s competitors in the Home Health Care industry. Thus, there is a contrast in profit between them regarding liquidity, analyst recommendations, risk, dividends, institutional ownership, earnings, and valuation.
Earnings & Valuation
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
LHC Group Inc. 1.81B 1.88 63.57M 1.77 61.54
BioScrip Inc. 708.90M 0.33 62.80M -0.93 0.00
Table 1 highlights LHC Group Inc. and BioScrip Inc.’s gross revenue, earnings per share (EPS), and valuation.
Profitability
Table 2 shows LHC Group Inc. and BioScrip Inc.’s return on assets, equity, and net margins.
Net Margins Return on Equity Return on Assets
LHC Group Inc. 3.51% 5.9% 3.8%
BioScrip Inc. -8.86% 46.9% -8.6%
Volatility & Risk
A 0.89 beta indicates that LHC Group Inc. is 11.00% less volatile than the S&P 500. BioScrip Inc. is 26.00% less volatile than S&P 500 volatility due to the company’s 0.74 beta.
Liquidity
LHC Group Inc.’s current ratio is 1.6, while its Quick Ratio is 1.6. Rival BioScrip Inc.’s current ratio is 1.8, and its Quick Ratio is 1.6. BioScrip Inc. is better equipped to clear short—and long-term obligations than LHC Group Inc.
Analyst Ratings
LHC Group Inc. and BioScrip Inc. Ratings and Recommendations are available next.
Sell Ratings Hold Ratings Buy Rating Rating Score
LHC Group Inc. 0 3 3 2.50
BioScrip Inc. 0 0 3 3.00
$116.29 is LHC Group Inc.’s consensus price target, while its potential upside is 7.40%. Competitively, the consensus price target of BioScrip Inc. is $3.67, which is a potential 101.65% upside. Based on the earlier data, analysts believe BioScrip Inc. looks more favorable than LHC Group Inc.
Insider & Institutional Ownership
LHC Group Inc. and BioScrip Inc. have shares owned by institutional investors of 96% and 83.3%, respectively. Insiders own roughly 1.3% of LHC Group Inc.’s shares. Competitively, insiders own 0.1% of BioScrip Inc.’s shares.
Performance
Here are both pretenders’ Weekly, Monthly, Quarterly, Half Yearly, Yearly, and YTD Performances.
Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
LHC Group Inc. 0.11% 3.26% 5.01% 11.4% 78.78% 16.3%
BioScrip Inc. -3% -11.02% -16.97% 12.54% 3.19% -9.52%
LHC Group Inc. had a bullish trend for the past year, while BioScrip Inc. had a bearish trend.
Summary
LHC Group Inc. beats BioScrip Inc. on 9 of the 13 factors.
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes; cardiac rehabilitation; infusion therapy; pain management; pharmaceutical administration; skilled observation and assessment; patient education; medically oriented social services; and physical, occupational, and speech therapy services. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits.
The Community-Based Services segment offers services, such as assistance with grooming, medication reminders, meal preparation, feeding, light housekeeping, respite care, transportation, and errand services to patients in their homes or a medical facility. The Facility-Based Services segment serves patients suffering from respiratory failure, neuromuscular disorders, cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments. The company also operates an institutional pharmacy, family health center, and family health clinic, offering physical therapy services. As of April 3, 2017, it operated 298 home health services locations, 72 hospice locations, 16 community-based service locations, and six long-term acute care hospitals with 8 locations. LHC Group, Inc. was founded in 1994 and is based in Lafayette, Louisiana.
BioScrip, Inc. provides home infusion services in the United States. The company prepares, delivers, administers, and monitors pharmaceutical treatments administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. It is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. BioScrip, Inc. offers its services at patientÂ’s homes, outpatient clinics, nursing facilities, physicianÂ’s offices, and ambulatory infusion centers. The company markets and sells its products and services through sales and marketing representatives, payor relationships, and other government programs. BioScrip, Inc. was founded in 1993 and is based in Denver, Colorado.